News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

Asthma patients to breathe easier

Media release

Asthma patients to breathe easier

New Zealanders will have easy access to an asthma medicine from 1 November.

Government drug-funder PHARMAC has announced a decision to widen access to salmeterol (Serevent) asthma inhalers, one of the group of treatments known as long-acting beta agonists (LABAs). These are used by people whose asthma is not adequately controlled using inhaled corticosteroids, such as beclomethasone (Beclazone), budesonide (Pulmicort) or fluticasone (Flixotide) alone.

From 1 November prescribing of salmeterol will be subject to a guideline, rather than the current need for Special Authority approval. This will make it easier for people to obtain salmeterol through their GP.

PHARMAC Medical Director Dr Peter Moodie says the decision will have a significant impact on people with asthma.

“We have seen evidence that greater asthma control is achieved by combining a LABA with inhaled steroid treatment, rather than increasing doses of inhaled steroids alone,” Dr Moodie says. “This decision will mean people will be able to add a LABA (salmeterol) to their treatment at a lower inhaled steroid dose.”

“We anticipate that widening access will result in an additional 15,000 people taking LABAs over the next three years.” Currently approximately 40,000 people are using LABAs.

Dr Moodie says the type of inhaler used for salmeterol, an aerosol, is the preferred type used by many New Zealanders. Currently, most people prescribed LABAs use a dry powder device. Dr Moodie says the type of inhaler will probably mean that most new patients prescribed a LABA will choose salmeterol.

The salmeterol access widening is anticipated to result in expenditure rising by about $8 million over the next five years.

The decision is the latest funding announcement by PHARMAC and follows decisions to widen access to the osteoporosis treatment alendronate, mycophenolate for transplants, diabetes medicine pioglitazone, and the aromatase inhibitors for breast cancer.

ENDS

© Scoop Media

 
 
 
Culture Headlines | Health Headlines | Education Headlines

 


Howard Davis: Controlling the High Ground

Stephen Johnson's raw and angry film not only poses important questions with scrupulous authenticity, but also provides a timely reminder of the genocidal consequences of casual bigotry and xenophobia. More>>

Howard Davis: Dryzabone - Robert Conolly's The Dry

After the terrible devastation caused by last year’s bushfires, which prompted hundreds of Australians to shelter in the ocean to escape incineration and destroyed uncountable amounts of wildlife, The Dry has been released during a totally different kind of dry spell. More>>


Howard Davis: Benjamin Ree's The Painter and The Thief

The Norwegian filmmaker had long been fascinated by art thieves who commit high-stakes crimes with a delicate touch when a chance Google search in 2015 uncovered a botched heist in Oslo. More>>


Howard Davis: Hit the Road, Jack - Chloé Zhao's Nomadland

Nomadland is perhaps the ultimately 'road' movie as it follows a group of dispossessed and disenfranchised vagabonds who find a form of communal refuge in camp sites and trailer parks after the economic contraction of 2008. More>>


Howard Davis: Byrneing Down the House - Spike Lee's American Utopia

Lee does an admirable job capturing Byrne's stunning live performance of his latest album, but the real star of the show is the staging. More>>


Howard Davis: The Phoenix Foundation Friend Ship Tour Docks in Wellington

A sense of local pride was certainly running high at the Opera House on Saturday night, as the lads ran through a tasty little set drawn mostly from their latest album Friend Ship (splash out for Xmas on the shocking pink extra-thick vinyl edition). More>>


 
 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 
 
  • Wellington
  • Christchurch
  • Auckland